Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

CDC tells pharmacies to give 4th covid shots to immunocompromised patients

by Medical Finance
in Coronavirus
CDC tells pharmacies to give 4th covid shots to immunocompromised patients
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

The Centers for Disease Control and Prevention reached out to pharmacists Wednesday to reinforce the message that people with moderate to severe immune suppression are eligible for fourth covid shots.

The conference call came a day after KHN reported that immunocompromised people were being turned away by pharmacy employees unfamiliar with the latest CDC guidelines.

White House chief of staff Ron Klain tweeted Wednesday morning that “immune-compromised people should get the shots they need,” adding that the CDC “is going to send stronger messages to pharmacies to make sure this happens.”

Pharmacists who joined the call said it took place midday Wednesday, a few hours after Klain’s tweet.

The CDC “reiterated the recommendations, running through case examples,” said Mitchel Rothholz, chief of governance and state affiliates for the American Pharmacists Association, who joined the CDC call.

Rothholz said he “asked for a prepared document … that clearly laid out the recommendations … so we can clearly and consistently communicate the message. They said they would but don’t know how long that will take.”

The CDC recommends one additional shot for the 7 million American adults whose weak immune systems make them more vulnerable to covid infection and death. This group includes people with medical conditions that impair their immune response to infection, as well as people who take immune-suppressing drugs because of organ transplants, cancer, or autoimmune diseases. Although people with obesity or diabetes are at high risk of developing severe disease or dying from covid, they’re not considered immunocompromised.

For other people ages 5 or older, the CDC recommends a primary vaccine series of two doses of mRNA vaccine. Adults also may receive the one-dose Johnson & Johnson vaccine, which the CDC says may be safer for people who have had a severe allergic reaction to an mRNA vaccine.

Anyone older than 12 can get one booster dose to combat waning immunity five months after the last shot in their primary series, regardless of which vaccine they received. Vaccines are not yet authorized for children younger than 5.

The CDC first recommended fourth shots for immunocompromised people in October. The agency has been working to educate pharmacists and other health providers since then, said CDC spokesperson Kristen Nordlund. Those efforts included a conference call with health officials from every state that had thousands of participants, as well as an additional call to physicians. The CDC has streamlined its website with booster advice several times. In its guidance to pharmacists, the CDC notes that patients don’t need to provide proof that they are immunocompromised.

Alyson Smith, who was turned away from a Walgreens drugstore after booking a vaccine appointment online, said she was pleased that the CDC is trying to help.

“I appreciate that the CDC is listening to patient and physician concerns and hope they will examine their processes for clear messaging and comprehensive dissemination of information,” Smith said.

In a statement before the publication of KHN’s first story, Walgreens said it continuously updates its pharmacists on new vaccine guidance.

Some health care leaders said the CDC should have done a better job of publicizing its advice on booster shots for the immunocompromised.

The call with pharmacists “should have been done many weeks ago,” said Dr. Eric Topol, founder and director of the Scripps Research Translational Institute. “I’m glad that the White House team is finally pushing forward on this.”

Dr. Ameet Kini, a professor of pathology and laboratory medicine at Loyola University Chicago Stritch School of Medicine, said he hopes the large pharmacies that have been turning people away will issue news releases and update their websites “explicitly stating that they are offering fourth doses” to immunocompromised people. He said pharmacies also need to update their patient portals and provide “clear guidance for their pharmacists.”




Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Inpatient COVID-19 Mortality Rates: What are the predictors?. Image Credit: CKA/ Shutterstock

What are the predictors of inpatient COVID-19 mortality rates?

by Medical Finance
May 20, 2022
0

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a severe infection that spreads swiftly within a population and has put...

Study: VarLOCK - sequencing independent, rapid detection of SARS-CoV-2 variants of concern for point-of-care testing, qPCR pipelines and national wastewater surveillance. Image Credit: Kateryna Kon/Shutterstock

VarLOCK approach for rapid detection of SARS-CoV-2 variants of concern and wastewater monitoring

by Medical Finance
May 20, 2022
0

A recent preprint study posted to the medRxiv* server discussed the expansion of the severe acute respiratory syndrome coronavirus...

Study: A single-cell atlas reveals shared and distinct immune responses and metabolism during SARS-CoV-2 and HIV-1 infections. Image Credit: Design_Cells / Shutterstock

Similarities and dissimilarities in immune responses and metabolism in SARS-CoV-2 and HIV-1 infections

by Medical Finance
May 20, 2022
0

Among the various viral diseases, two of the most prevalent viruses that have affected millions of lives are severe acute...

Study: Comparison of Moderna Versus Pfizer-Biontech COVID-19 Vaccine Outcomes: A Target Trial Emulation Study In the U.S. Veterans Affairs Healthcare System. Image Credit: BaLL LunLa/Shutterstock

Comparing the Moderna and Pfizer-Biontech vaccines against SARS-CoV-2 infection

by Medical Finance
May 20, 2022
0

Several vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed to combat the ongoing coronavirus disease 2019...

Long-term exposure to air pollutants may increase the incidence of COVID-19

Long-term exposure to air pollutants may increase the incidence of COVID-19

by Medical Finance
May 20, 2022
0

Long term exposure to ambient air pollution may heighten the risk of COVID-19 infection, suggests research published online in the...

Study: Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues. Image Credit: CROCOTHERY/Shutterstock

Unraveling the early host-immune response to SARS-CoV-2 in mild COVID-19 infections

by Medical Finance
May 20, 2022
0

In a study posted recently to the bioRxiv* preprint server, researchers determined the early immune response to severe acute respiratory...

Next Post
Omicron variant found to be much less sensitive to neutralizing antibodies than Delta

Omicron variant found to be much less sensitive to neutralizing antibodies than Delta

Small cluster of neurons in the brain stem found to coordinate vocalization with breathing

Small cluster of neurons in the brain stem found to coordinate vocalization with breathing

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Biophysical fitness landscape of the SARS-CoV-2 Delta variant receptor binding domain. Image Credit: Lazy_Bear / Shutterstock.com
    Biophysical fitness profile of SARS-CoV-2 Delta variant
  • Study: COVID-19 mortality among working-age Americans in 46 states, by industry and occupation. Image Credit: Eldar Nurkovic / Shutterstock
    New U.S. COVID mortality data by occupation
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply